The (R)-enantiomer of CE3F4 is a preferential inhibitor of human exchange protein directly activated by cyclic AMP isoform 1 (Epac1).

[1]  F. Dekker,et al.  Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions , 2013, Pharmacological Reviews.

[2]  Xiaodong Cheng,et al.  A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and Invasion , 2013, Molecular Pharmacology.

[3]  F. Lezoualc’h,et al.  Identification of a Tetrahydroquinoline Analog as a Pharmacological Inhibitor of the cAMP-binding Protein Epac* , 2012, The Journal of Biological Chemistry.

[4]  Virgil L. Woods,et al.  Isoform-specific antagonists of exchange proteins directly activated by cAMP , 2012, Proceedings of the National Academy of Sciences.

[5]  Xiaodong Cheng,et al.  A Fluorescence-Based High-Throughput Assay for the Discovery of Exchange Protein Directly Activated by Cyclic AMP (EPAC) Antagonists , 2012, PloS one.

[6]  F. Lezoualc’h,et al.  Rap-linked cAMP signaling Epac proteins: compartmentation, functioning and disease implications. , 2011, Cellular signalling.

[7]  J. Bos,et al.  Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B , 2008, Nature.

[8]  Gopalakrishnan Ramamurthy,et al.  Cytoplasmic cAMP concentrations in intact cardiac myocytes. , 2008, American journal of physiology. Cell physiology.

[9]  Andrew J. Murray.  Pharmacological PKA Inhibition: All May Not Be What It Seems , 2008, Science Signaling.

[10]  S. Døskeland,et al.  Cyclic nucleotide analogs as probes of signaling pathways , 2008, Nature Methods.

[11]  A. Wittinghofer,et al.  Ligand-mediated Activation of the cAMP-responsive Guanine Nucleotide Exchange Factor Epac* , 2003, Journal of Biological Chemistry.

[12]  S. Døskeland,et al.  cAMP Analog Mapping of Epac1 and cAMP Kinase , 2003, Journal of Biological Chemistry.

[13]  J. Bos,et al.  Epac-selective cAMP Analog 8-pCPT-2′-O-Me-cAMP as a Stimulus for Ca2+-induced Ca2+ Release and Exocytosis in Pancreatic β-Cells* , 2003, The Journal of Biological Chemistry.

[14]  S. Døskeland,et al.  A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK , 2002, Nature Cell Biology.

[15]  J. Caldwell,et al.  Putting chirality to work: the strategy of chiral switches , 2002, Nature Reviews Drug Discovery.

[16]  A. Wittinghofer,et al.  Mechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs* , 2000, The Journal of Biological Chemistry.

[17]  P. Bouyssou,et al.  Synthesis of 7- and 5,7-Substituted-6-fluoro-2-methyl-1,2,3,4- tetrahydroquinolines: Convenient Precursors of Quinolone Antibacterial Agents. , 1992 .

[18]  P. Bouyssou,et al.  Synthesis of 7‐ and 5,7‐substituted‐6‐fluoro‐2‐methyl‐1,2,3,4‐tetrahydroquinolines: Convenient precursors of quinolone antibacterial agents , 1992 .

[19]  W. B. Gleason,et al.  Synthesis, absolute configuration, and antibacterial activity of 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H- benzo[ij]quinolizine-2-carboxylic acid. , 1987, Journal of medicinal chemistry.